Sleep Apnea is Associated With Accelerated Vascular Aging: Results From 2 European Community‐Based Cohort Studies

Background The mechanisms underlying the association between obstructive sleep apnea (OSA) and cardiovascular disease may include accelerated vascular aging. The aim was to compare the magnitude of vascular aging in patients with high versus low risk of OSA. Methods and Results In 2 community‐based studies, the PPS3 (Paris Prospective Study 3) and the Maastricht Study, high risk of OSA was determined with the Berlin questionnaire (a screening questionnaire for OSA). We assessed carotid artery properties (carotid intima‐media thickness, Young’s elastic modulus, carotid‐femoral pulse wave velocity, carotid pulse wave velocity, carotid diameter using high precision ultrasound echography), and carotid‐femoral pulse wave velocity (in the Maastricht Study only). Regression coefficients were estimated on pooled data using multivariate linear regression. A total of 8615 participants without prior cardiovascular disease were included (6840 from PPS3, 62% men, mean age 59.5±6.2 years, and 1775 from the Maastricht Study, 51% men, 58.9±8.1 years). Overall, high risk of OSA prevalence was 16.8% (n=1150) in PPS3 and 23.8% (n=423) in the Maastricht Study. A high risk of OSA was associated with greater carotid intima‐media thickness (β=0.21; 0.17–0.26), Young’s elastic modulus (β=0.21; 0.17–0.25), carotid‐femoral pulse wave velocity (β=0.24; 0.14–0.34), carotid pulse wave velocity (β=0.31; 0.26–0.35), and carotid diameter (β=0.43; 0.38–0.48), after adjustment for age, sex, total cholesterol, smoking, education level, diabetes mellitus, heart rate, and study site. Consistent associations were observed after additional adjustments for mean blood pressure, body mass index, or antihypertensive medications. Conclusions These data lend support for accelerated vascular aging in individuals with high risk of OSA. This may, at least in part, underlie the association between OSA and cardiovascular disease.

Download Full-text

Plasma expression of microRNA-425-5p and microRNA-451a as biomarkers of cardiovascular disease in rheumatoid arthritis patients

Scientific Reports ◽

10.1038/s41598-021-95234-w ◽

2021 ◽

Vol 11 (1) ◽

Author(s):

Delia Taverner ◽

Dídac Llop ◽

Roser Rosales ◽

Raimon Ferré ◽

Luis Masana ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Cardiovascular Disease ◽

Pulse Wave Velocity ◽

Wave Velocity ◽

Pulse Wave ◽

Disease Risk ◽

Intima Media Thickness ◽

Carotid Intima Media Thickness ◽

Media Thickness ◽

Epigenetic Biomarkers

AbstractTo validate in a cohort of 214 rheumatoid arthritis patients a panel of 10 plasmatic microRNAs, which we previously identified and that can facilitate earlier diagnosis of cardiovascular disease in rheumatoid arthritis patients. We identified 10 plasma miRs that were downregulated in male rheumatoid arthritis patients and in patients with acute myocardial infarction compared to controls suggesting that these microRNAs could be epigenetic biomarkers for cardiovascular disease in rheumatoid arthritis patients. Six of those microRNAs were validated in independent plasma samples from 214 rheumatoid arthritis patients and levels of expression were associated with surrogate markers of cardiovascular disease (carotid intima-media thickness, plaque formation, pulse wave velocity and distensibility) and with prior cardiovascular disease. Multivariate analyses adjusted for traditional confounders and treatments showed that decreased expression of microRNA-425-5p in men and decreased expression of microRNA-451 in women were significantly associated with increased (β = 0.072; p = 0.017) and decreased carotid intima-media thickness (β = −0.05; p = 0.013), respectively. MicroRNA-425-5p and microRNA-451 also increased the accuracy to discriminate patients with pathological carotid intima-media thickness by 1.8% (p = 0.036) in men and 3.5% (p = 0.027) in women, respectively. In addition, microRNA-425-5p increased the accuracy to discriminate male patients with prior cardiovascular disease by 3% (p = 0.008). Additionally, decreased expression of microRNA-451 was significantly associated with decreased pulse wave velocity (β = −0.72; p = 0.035) in overall rheumatoid arthritis population. Distensibility showed no significant association with expression levels of the microRNAs studied. We provide evidence of a possible role of microRNA-425-5p and microRNA-451 as useful epigenetic biomarkers to assess cardiovascular disease risk in patients with rheumatoid arthritis.

Download Full-text

Abstract: P822 PULSE WAVE VELOCITY, CAROTID INTIMA-MEDIA THICKNESS AND CARDIOVASCULAR DISEASE IN THE BEAVER DAM OFFSPRING STUDY (BOSS)

Atherosclerosis Supplements ◽

10.1016/s1567-5688(09)71176-6 ◽

2009 ◽

Vol 10 (2) ◽

pp. e1211

Author(s):

W Zhong ◽

K Cruickshanks ◽

C Schubert ◽

FJ Nieto ◽

J Pankow ◽

...

Keyword(s):

Cardiovascular Disease ◽

Pulse Wave Velocity ◽

Wave Velocity ◽

Pulse Wave ◽

Intima Media Thickness ◽

Carotid Intima Media Thickness ◽

Media Thickness ◽

Beaver Dam

Download Full-text

Cardio-ankle Vascular Index Is More Closely Associated Than Brachial-ankle Pulse Wave Velocity With Variables Predicting Future Cardiovascular Disease in Patients With Diabetes

10.21203/rs.3.rs-876077/v1 ◽

2021 ◽

Author(s):

Taro Saigusa ◽

Kentaro Watanabe ◽

Yurika Hada ◽

Kota Ishii ◽

Wataru Kameda ◽

...

Keyword(s):

Risk Factors ◽

Cardiovascular Disease ◽

Pulse Wave Velocity ◽

Wave Velocity ◽

Pulse Wave ◽

Intima Media Thickness ◽

Carotid Intima Media Thickness ◽

Patients With Diabetes

Abstract Background: This study aimed to compare the usefulness of arterial stiffness parameters, cardio-ankle vascular index (CAVI) and brachial-ankle pulse wave velocity (baPWV), for evaluating future cardiovascular disease (CVD) in subjects with diabetes.Methods: The study subjects were 277 patients with type 1 or type 2 diabetes. All subjects were evaluated for vascular stiffness using CAVI (n = 154) or baPWV (n = 123). Carotid intima-media thickness (IMT) and the Suita score were also measured because these are established risk factors for future CVD. Associations of both CAVI and baPWV with these established parameters were evaluated in all subjects, and then in 172 subjects with adjustment for covariates by using propensity score matching.Results: In all subjects, CAVI and baPWV correlated significantly with both IMT (r = 0.470, P < 0.001, and r = 0.256, P = 0.004, respectively) and the Suita score (r = 0.558, P < 0.001, and r = 0.360, P < 0.001, respectively). The correlation between CAVI and IMT was more significant than that between baPWV and IMT (Z = 2.03, P = 0.042).　Similarly, the correlation between CAVI and the Suita score was more significant than that between baPWV and the Suita score (Z = 2.07, P = 0.039). After adjustment by matching, significant correlations between CAVI and IMT (r = 0.459, P < 0.001) and between CAVI and the Suita score (r = 0.526, P < 0.001) were preserved, though only the association between baPWV and the Suita score was significant (r = 0.270, P = 0.011) while that between baPWV and IMT showed no significance. Again, CAVI showed a significantly stronger association with the Suita score than baPWV (Z = 1.99, P = 0.046).Conclusions: CAVI is more closely associated than baPWV with variables predicting future CVD in patients with diabetes.

Download Full-text